Annals of the Rheumatic Diseases

Title Publication Date Language Citations
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database2007/01/12English612
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group2009/05/18English610
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis2015/01/05English608
Long-term patient survival in ANCA-associated vasculitis2010/11/24English595
Shoulder disorders in general practice: incidence, patient characteristics, and management.1995/12/01English580
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)2005/05/01English571
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 20172020/05/12English568
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials2011/02/03English562
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab2007/03/15English551
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study2009/03/17English543
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update2020/05/20English539
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)2013/10/04English535
High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes2004/03/01English532
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate2008/05/19English528
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system2005/01/01English522
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study2013/05/18English519
Still's disease in the adult.1971/03/01English519
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores2010/11/10English517
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force2014/04/16English503
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome2016/07/25English500
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations.1989/04/01English500
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)2006/06/30English500
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study2013/05/16English498
EULAR evidence-based recommendations for the management of fibromyalgia syndrome2007/07/20English492
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial2014/01/30English489
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach2003/11/01English489
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial2005/08/01English488
Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints2013/06/06English488
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment2009/01/15English481
Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis2014/06/17English475